Donepezil (E2020): A new acetylcholinesterase inhibitor. Review of its pharmacology, pharmacokinetics, and utility in the treatment of Alzheimer's disease

Expert Opinion on Investigational Drugs

Volumn 6, Issue 10, 1997, Pages 1527-1535

  Heydorn, W E ^a  

^a H LUNDBECK A S   (Denmark)

Author keywords

Acetylcholinesterase inhibitor; Alzheimer's disease; Dementia; Donepezil; E2020

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR; DONEPEZIL; TACRINE;

ALZHEIMER DISEASE; BIOAVAILABILITY; DOSE RESPONSE; ENZYME INHIBITION; HUMAN; IN VITRO STUDY; LEARNING; REVIEW; WORKING MEMORY;

EID: 0030879494     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.6.10.1527     Document Type: Review

References (44)